Association of Fenofibrate Therapy With Long-term Cardiovascular Risk in Statin-Treated Patients With Type 2 Diabetes | Zendy

Marshall B. Elam | Zendy; Henry N. Ginsberg | Zendy; Laura Lovato | Zendy; Marshall A. Corson | Zendy; Joseph F. Largay | Zendy; Lawrence A. Leiter | Zendy; Carlos López | Zendy; Patrick J. O’Connor | Zendy; Mary Ellen Sweeney | Zendy; Daniel Weiß | Zendy; William T. Friedewald | Zendy; John B. Buse | Zendy; Hertzel C. Gerstein | Zendy; Jeffrey L. Probstfield | Zendy; Richard H. Grimm | Zendy; Faramarz IsmailBeigi | Zendy; David C. Goff | Zendy; Jerome L. Fleg | Zendy; Yves Rosenberg | Zendy; Robert P. Byington | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Association of Fenofibrate Therapy With Long-term Cardiovascular Risk in Statin-Treated Patients With Type 2 Diabetes

Author(s) -

Marshall B. Elam,

Henry N. Ginsberg,

Laura Lovato,

Marshall A. Corson,

Joseph F. Largay,

Lawrence A. Leiter,

Carlos López,

Patrick J. O’Connor,

Mary Ellen Sweeney,

Daniel Weiß,

William T. Friedewald,

John B. Buse,

Hertzel C. Gerstein,

Jeffrey L. Probstfield,

Richard H. Grimm,

Faramarz IsmailBeigi,

David C. Goff,

Jerome L. Fleg,

Yves Rosenberg,

Robert P. Byington

Publication year - 2016

Publication title -

jama cardiology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 6.108

H-Index - 63

eISSN - 2380-6591

pISSN - 2380-6583

DOI - 10.1001/jamacardio.2016.4828

Subject(s) - medicine , fenofibrate , type 2 diabetes , diabetes mellitus , statin , hypertriglyceridemia , population , physical therapy , triglyceride , cholesterol , endocrinology , environmental health

Patients with type 2 diabetes are at high risk of cardiovascular disease (CVD) in part owing to hypertriglyceridemia and low high-density lipoprotein cholesterol. It is unknown whether adding triglyceride-lowering treatment to statin reduces this risk.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research